Overview
Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of aspirin and/or folic acid may be effective in preventing recurrent polyps in patients who have had polyps removed previously. PURPOSE: Randomized clinical trial to determine the effectiveness of aspirin and/or folic acid in preventing the recurrence of colorectal polyps.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Queen's Medical CentreTreatments:
Aspirin
Folic Acid
Vitamin B Complex
Criteria
DISEASE CHARACTERISTICS:- Histologically confirmed colorectal adenoma removed within the past 6 months
- Greater than 0.5 cm after fixation or greater than 0.7 cm at time of removal
- OR
- Any size with a history of prior colorectal adenoma removal(s)
- Removed via colonoscopy, flexi-sigmoidoscopy (provided barium enema has been
performed), or transanal endoscopic microsurgery
- Removal must be considered complete with follow-up to be done within 6 months
- No prior resection of large bowel (e.g., hemi-colectomy or greater, anterior
resection, or subtotal colectomy)
PATIENT CHARACTERISTICS:
Age:
- 75 and under
Performance status:
- Not specified
Life expectancy:
- Not specified
Hematopoietic:
- No active bleeding disorders
Hepatic:
- Not specified
Renal:
- Not specified
Cardiovascular:
- No unstable heart conditions
Pulmonary:
- No unstable asthma
Other:
- Not pregnant and no potential to become pregnant within the next 3 years
- No unstable diabetes
- No active upper gastrointestinal ulceration
- No known aspirin intolerance or sensitivity
- No other serious medical conditions that would preclude study participation
PRIOR CONCURRENT THERAPY:
Biologic therapy:
- Not specified
Chemotherapy:
- Not specified
Endocrine therapy:
- Not specified
Radiotherapy:
- Not specified
Surgery:
- See Disease Characteristics
Other:
- No other concurrent folic acid
- No concurrent anticoagulants
- No other prior or concurrent non-steroidal anti-inflammatory drugs, prescribed or
self-medicated (more than 3 tablets per week)